bah-roo

InvestmentWisdom

  • When Cramer Says Buy, I Check the Exit

    When Cramer Says Buy, I Check the Exit

    When Jim Cramer says “buy,” the real question isn’t what he likes. It’s whether you’re late. This week he’s pounding the table on Marvell (MRVL) and Bausch Health (BHC). One is an AI infrastructure darling with hyperscaler tailwinds. The other is a battered pharma turnaround story that Wall Street still doesn’t fully trust. Two very…

  • SanDisk’s NAND Boom Is Real — But Don’t Pretend It’s Forever

    SanDisk’s NAND Boom Is Real — But Don’t Pretend It’s Forever

    SanDisk Is Riding a NAND Supercycle. The Real Question Is: Are You Too Late? NAND memory is back. Prices are ripping higher, supply is tight, and hyperscalers are throwing money at enterprise SSDs like it’s 2021 all over again. SanDisk — freshly spun off from Western Digital and now a pure-play NAND bet — is…

  • Cramer’s Marvell and Bausch Calls Aren’t Crazy — But Timing Is Everything

    Cramer’s Marvell and Bausch Calls Aren’t Crazy — But Timing Is Everything

    When Jim Cramer pounds the table, traders listen. They shouldn’t follow blindly — but they should pay attention. His latest calls? Buy Marvell Technology and Bausch Health. Two very different beasts. One riding the AI chip frenzy. The other crawling out of a debt-heavy pharma mess. So is this actionable alpha — or just good…